Celltrion Pursues EMA Approval for Actemra Biosimilar -February 14, 2024 at 1249 am EST - Marketscreener.com
| 068270 Stock | 194,400 500.00 0.26% |
About 55% of Celltrion's investor base is interested to short. The analysis of current outlook of investing in Celltrion suggests that many traders are impartial regarding Celltrion's prospects. The current market sentiment, together with Celltrion's historical and current headlines, can help investors time the market. In addition, many technical investors use Celltrion stock news signals to limit their universe of possible portfolio assets.
Celltrion |
Celltrion Pursues EMA Approval for Actemra Biosimilar -February 14, 2024 at 1249 am EST Marketscreener.com
Read at news.google.com
 |
Celltrion Fundamental Analysis
We analyze Celltrion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celltrion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celltrion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Celltrion is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Celltrion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celltrion stock to make a market-neutral strategy. Peer analysis of Celltrion could also be used in its relative valuation, which is a method of valuing Celltrion by comparing valuation metrics with similar companies.
Peers
Celltrion Related Equities
| 109860 | Dongil Metal | 2.28 | ||||
| 003690 | Korean Reinsurance | 2.11 | ||||
| 060480 | Kukil Metal | 0.69 | ||||
| 128660 | PJ Metal | 0.33 | ||||
| 007530 | Youngsin Metal | 0.41 | ||||
| 018470 | Choil Aluminum | 0.49 | ||||
| 004140 | Dongbang Transport | 0.69 |
Complementary Tools for Celltrion Stock analysis
When running Celltrion's price analysis, check to measure Celltrion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion is operating at the current time. Most of Celltrion's value examination focuses on studying past and present price action to predict the probability of Celltrion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion's price. Additionally, you may evaluate how the addition of Celltrion to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |